Oncogenic Risk of Mycophenolate Mofetil Use in Dermatology Versus Transplant Groups

The number of malignant cases that developed after taking MMF for at least 5 years among dermatologic conditions versus transplant patients. The transplant group had statistically higher malignancy cases compared to the dermatologic conditions group (p<0.0001).